Brian Edwin Cathers - Net Worth and Insider Trading
Brian Edwin Cathers Net Worth
The estimated net worth of Brian Edwin Cathers is at least $359,162 dollars as of 2025-05-14. Brian Edwin Cathers is the Chief Scientific Officer of Global Blood Therapeutics Inc and owns about 5,244 shares of Global Blood Therapeutics Inc (GBT) stock worth over $359,162. Details can be seen in Brian Edwin Cathers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Edwin Cathers has not made any transactions after 2020-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Edwin Cathers
Brian Edwin Cathers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Edwin Cathers owns 1 companies in total, including Global Blood Therapeutics Inc (GBT) .
Click here to see the complete history of Brian Edwin Cathers’s form 4 insider trades.
Insider Ownership Summary of Brian Edwin Cathers
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2020-08-20 | Chief Scientific Officer |
Brian Edwin Cathers Latest Holdings Summary
Brian Edwin Cathers currently owns a total of 1 stock. Brian Edwin Cathers owns 5,244 shares of Global Blood Therapeutics Inc (GBT) as of August 20, 2020, with a value of $359,162.
Latest Holdings of Brian Edwin Cathers
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2020-08-20 | 5,244 | 68.49 | 359,162 |
Holding Weightings of Brian Edwin Cathers
Brian Edwin Cathers Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Edwin Cathers has made a total of 1 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Global Blood Therapeutics Inc is the sale of 2,200 shares on August 20, 2020, which brought Brian Edwin Cathers around $140,294.
Insider Trading History of Brian Edwin Cathers
- 1
Brian Edwin Cathers Trading Performance
Brian Edwin Cathers Ownership Network
Ownership Network List of Brian Edwin Cathers
Ownership Network Relation of Brian Edwin Cathers
Brian Edwin Cathers Owned Company Details
What does Global Blood Therapeutics Inc do?
Who are the key executives at Global Blood Therapeutics Inc?
Brian Edwin Cathers is the Chief Scientific Officer of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .
Global Blood Therapeutics Inc (GBT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Global Blood Therapeutics Inc Insider Transactions
Brian Edwin Cathers Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Edwin Cathers. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Brian Edwin Cathers's mailing address is: Suite 300 South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
